Larson Financial Group’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$90 Sell
6
-38
-86% -$570 ﹤0.01% 3151
2025
Q1
$710 Buy
+44
New +$710 ﹤0.01% 2465